Journal Aims

The objective of the editor’s and editorial board of the Journal of Pharmacy Practice, as well as that of Sage is to offer the practicing pharmacist topical, pertinent, and useful information to support pharmacy practice, pharmacotherapy and medication therapy management, as well as to expand the pharmacist’s professional horizons.

Journal Scope

The readership, like the pharmacy profession, is diverse and so are the topics covered in every issue. Since the walls between pharmacy practice sites remain distinct yet continue to blend in the continuum of care, each pharmacy practitioner needs to be primed on a wide variety of practice essentials, new advents, and future trends. The journal sections include research articles, review articles, adverse drug events, case reports, and editorials. Pharmacotherapy topics covered are broad and vary to include internal medicine, infectious diseases, critical care, emergency medicine, cardiology, oncology, neurology, psychiatry, pediatrics, ambulatory care and geriatrics.

Practice issues, practice settings, therapeutics issues, disease management, drug information, pharmacy education, medication compliance, artificial intelligence, research, government, legal, and regulatory issues, are reviewed in a timely manner and of interest for publication in JPP. The journal will also cover issues that expand the pharmacist’s scope of practice such as provider status, prescribing, ordering lab tests, test and treat, performing physical assessment, collaborative agreements, immunizer, credentialing, billing and reimbursement for services. On occasion, the journal will focus on a single topic that provides the reader with a thorough review of that topic written by experienced and accomplished practitioners.

We intend that the Journal of Pharmacy Practice will be of practical value to you. It has been used in daily practice as an informational reference and for teaching purposes. Every effort has been made to ensure the correct usage of generic and trade names and to verify drug doses. The ultimate responsibility, however, lies with the practitioner. Please convey any errors or comments to the Editor-In-Chief.